[Experience of olokizumab use in COVID-19 patients].

Autor: Antonov VN; South Ural State Medical University.; Regional Clinical Hospital №3., Ignatova GL; South Ural State Medical University.; Regional Clinical Hospital №3., Pribytkova OV; South Ural State Medical University.; Regional Clinical Hospital №3., Sleptsova SS; Ammosov North-Eastern Federal University., Strebkova EA; Seredavin Samara Regional Clinical Hospital.; Samara State Medical University, Samara., Khudyakova EA; Luke of Crimea Stary Oskol District Hospital, Belgorod Region., Simakov AI; Pacific State Medical University.; Territorial Clinical Hospital №2., Rabets SY; Norilsk Inter-District Hospital №1., Tikhonova EP; Voyno-Yasenetsky Krasnoyarsk State Medical University.; Karpovich Krasnoyarsk Inter-District Clinical Emergency Hospital., Kurmaeva DY; Penza Regional Clinical Tertiary Care Centre., Petrushin MA; Tver Region Regional Clinical Hospital., Mashkov AS; Voronovskoye Moscow Clinical Center for Infectious Diseases., Gayazova EV; Nizhny Novgorod Region City Clinical Hospital №3 (Nizhny Novgorod Geriatric Center)., Yasheva IV; Temporary Infectious Diseases Hospital for Coronavirus Disease based at the Cherkess City Clinical Hospital., Andreev MA; Republican Tuberculosis Dispensary., Khinovker VV; Siberian Clinical Research Center., Karpunin AY; Regional Clinical Hospital., Berezhanskiy BV; R-Pharm JSC.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2020 Dec 15; Vol. 92 (12), pp. 148-154. Date of Electronic Publication: 2020 Dec 15.